Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016, Article ID 4370142, 16 pages
http://dx.doi.org/10.1155/2016/4370142
Research Article

Human Hepatocyte-Derived Induced Pluripotent Stem Cells: MYC Expression, Similarities to Human Germ Cell Tumors, and Safety Issues

1Pediatric Surgery Laboratory, Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland
2School of Life Sciences and “Frontiers in Genetics” National Program, École Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland
3Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland
4Division of Clinical Pathology, Geneva University Hospitals, 1211 Geneva, Switzerland

Received 5 July 2015; Accepted 26 November 2015

Academic Editor: Franca Fagioli

Copyright © 2016 Carmen Unzu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Y. Zhang, P. E. de Almeida, and J. C. Wu, “Teratoma formation: a tool for monitoring pluripotency in stem cell research,” in Current Protocols in Stem Cell Biology, John Wiley & Sons, 2008. View at Google Scholar
  2. R. J. Kurman, M. L. Carcangiu, C. S. Herrington, and R. H. Young, Eds., WHO Classification of Tumours of Female Reproductive Organs, IARC Press, Lyon, France, 4th edition, 2014.
  3. I. Ben-Porath, M. W. Thomson, V. J. Carey et al., “An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors,” Nature Genetics, vol. 40, no. 5, pp. 499–507, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Miura, Y. Okada, T. Aoi et al., “Variation in the safety of induced pluripotent stem cell lines,” Nature Biotechnology, vol. 27, no. 8, pp. 743–745, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. J. J. Cunningham, T. M. Ulbright, M. F. Pera, and L. H. J. Looijenga, “Lessons from human teratomas to guide development of safe stem cell therapies,” Nature Biotechnology, vol. 30, no. 9, pp. 849–857, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Griscelli, O. Féraud, N. Oudrhiri et al., “Malignant germ cell-like tumors, expressing Ki-1 antigen (CD30), are revealed during in vivo differentiation of partially reprogrammed human-induced pluripotent stem cells,” The American Journal of Pathology, vol. 180, no. 5, pp. 2084–2096, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Kim, A. Doi, B. Wen et al., “Epigenetic memory in induced pluripotent stem cells,” Nature, vol. 467, no. 7313, pp. 285–290, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Birraux, O. Menzel, B. Wildhaber, C. Jond, T. H. Nguyen, and C. Chardot, “A step toward liver gene therapy: efficient correction of the genetic defect of hepatocytes isolated from a patient with Crigler-Najjar syndrome type 1 with lentiviral vectors,” Transplantation, vol. 87, no. 7, pp. 1006–1012, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. I. Barde, B. Rauwel, R. M. Marin-Florez et al., “A KRAB/KAP1-miRNA cascade regulates erythropoiesis through stage-specific control of mitophagy,” Medecine/Sciences, vol. 30, no. 1, pp. 12–15, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. C. A. Sommer, A. G. Sommer, T. A. Longmire et al., “Excision of reprogramming transgenes improves the differentiation potential of iPS cells generated with a single excisable vector,” STEM CELLS, vol. 28, no. 1, pp. 64–74, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. C. E. Pasi, A. Dereli-Öz, S. Negrini et al., “Genomic instability in induced stem cells,” Cell Death and Differentiation, vol. 18, no. 5, pp. 745–753, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. B. W. Carey, S. Markoulaki, C. Beard, J. Hanna, and R. Jaenisch, “Single-gene transgenic mouse strains for reprogramming adult somatic cells,” Nature Methods, vol. 7, no. 1, pp. 56–59, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Coulouarn, C. Cavard, L. Rubbia-Brandt et al., “Combined hepatocellular-cholangiocarcinomas exhibit progenitor features and activation of Wnt and TGFβ signaling pathways,” Carcinogenesis, vol. 33, no. 9, pp. 1791–1796, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Miettinen, Z. Wang, P. A. McCue et al., “SALL4 expression in germ cell and non-germ cell tumors: a systematic immunohistochemical study of 3215 cases,” The American Journal of Surgical Pathology, vol. 38, no. 3, pp. 410–420, 2014. View at Publisher · View at Google Scholar
  15. J. W. Oosterhuis and L. H. J. Looijenga, “Testicular germ-cell tumours in a broader perspective,” Nature Reviews Cancer, vol. 5, no. 3, pp. 210–222, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Abiko, M. Mandai, J. Hamanishi et al., “Oct4 expression in immature teratoma of the ovary: relevance to histologic grade and degree of differentiation,” The American Journal of Surgical Pathology, vol. 34, no. 12, pp. 1842–1848, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Wahlström and M. A. Henriksson, “Impact of MYC in regulation of tumor cell metabolism,” Biochimica et Biophysica Acta, vol. 1849, no. 5, pp. 563–569, 2015. View at Publisher · View at Google Scholar
  18. M. B. Ruzinova, T. Caron, and S. J. Rodig, “Altered subcellular localization of c-Myc protein identifies aggressive B-cell lymphomas harboring a c-MYC translocation,” The American Journal of Surgical Pathology, vol. 34, no. 6, pp. 882–891, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. T. M. Ulbright, S. K. Tickoo, D. M. Berney, and J. R. Srigley, “Best practices recommendations in the application of immunohistochemistry in testicular tumors: report from the International Society of Urological Pathology consensus conference,” The American Journal of Surgical Pathology, vol. 38, no. 8, pp. e50–e59, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. D. L. Zynger, N. D. Dimov, C. Luan, B. Tean Teh, and X. J. Yang, “Glypican 3: a novel marker in testicular germ cell tumors,” The American Journal of Surgical Pathology, vol. 30, no. 12, pp. 1570–1575, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. C. H. P. van den Akker, H. Schierbeek, T. Rietveld et al., “Human fetal albumin synthesis rates during different periods of gestation,” The American Journal of Clinical Nutrition, vol. 88, no. 4, pp. 997–1003, 2008. View at Google Scholar · View at Scopus
  22. Y. Horie and M. Kato, “Hepatoid variant of yolk sac tumor of the testis,” Pathology International, vol. 50, no. 9, pp. 754–758, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Sauter, J. N. Ebele, J. I. Epstein, and I. A. Sesterhenn, Eds., WHO Classification of Tumours of the Urinary System and Male Genital Organs, IARC Press, Lyon, France, 2004.
  24. A. McIntyre, D. Gilbert, N. Goddard, L. Looijenga, and J. Shipley, “Genes, chromosomes and the development of testicular germ cell tumors of adolescents and adults,” Genes Chromosomes and Cancer, vol. 47, no. 7, pp. 547–557, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Vilette, R. Emanoil-Ravier, J. Tobaly, and J. Peries, “Studies on four cellular proto-oncogenes and their expression in PCC4 embryonal carcinoma cells: amplification of c-Ki-ras oncogene,” Biochemical and Biophysical Research Communications, vol. 128, no. 2, pp. 513–519, 1985. View at Publisher · View at Google Scholar · View at Scopus
  26. I. Damjanov and P. W. Andrews, “The terminology of teratocarcinomas and teratomas,” Nature Biotechnology, vol. 25, no. 11, p. 1212, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. N. G. Kooreman and J. C. Wu, “Tumorigenicity of pluripotent stem cells: biological insights from molecular imaging,” Journal of the Royal Society Interface, vol. 7, supplement 6, pp. S753–S763, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. G. B. Pierce Jr., F. J. Dixon Jr., and E. L. Verney, “Teratocarcinogenic and tissue-forming potentials of the cell types comprising neoplastic embryoid bodies,” Laboratory Investigation, vol. 9, pp. 583–602, 1960. View at Google Scholar
  29. D. Herszfeld, E. Wolvetang, E. Langton-Bunker et al., “CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells,” Nature Biotechnology, vol. 24, no. 3, pp. 351–357, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Yanger, Y. Zong, L. R. Maggs et al., “Robust cellular reprogramming occurs spontaneously during liver regeneration,” Genes and Development, vol. 27, no. 7, pp. 719–724, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Almstrup, C. E. Hoei-Hansen, U. Wirkner et al., “Embryonic stem cell-like features of testicular carcinoma in situ revealed by genome-wide gene expression profiling,” Cancer Research, vol. 64, no. 14, pp. 4736–4743, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. R. I. Skotheim, G. E. Lind, O. Monni et al., “Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development,” Cancer Research, vol. 65, no. 13, pp. 5588–5598, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. E. Rajpert-De Meyts, “Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects,” Human Reproduction Update, vol. 12, no. 3, pp. 303–323, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Okita, T. Ichisaka, and S. Yamanaka, “Generation of germline-competent induced pluripotent stem cells,” Nature, vol. 448, no. 7151, pp. 313–317, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Nakagawa, N. Takizawa, M. Narita, T. Ichisaka, and S. Yamanaka, “Promotion of direct reprogramming by transformation-deficient Myc,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 32, pp. 14152–14157, 2010. View at Publisher · View at Google Scholar · View at Scopus